Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
General Anesthesia Regimen for DBS in Parkinson's Disease
NCT06658132Completed
- Sponsor
- Renji Hospital
- Start
- Oct 2024
- Primary completion
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of esketamine in Parkinson's disease (PD), sponsored by Renji Hospital. Primary endpoint: Proportion of MER signal recordings with high NRMS. Started Oct 2024; status: completed.
02
Drugs
esketamine
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT06658132.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06658132.